Adjuvanted pertussis vaccine (Dynavax Technologies/Serum Institute of India)

N/A

Report date: 2024/04/07 11:35:06

Base Information

Drug NameAdjuvanted pertussis vaccine (Dynavax Technologies/Serum Institute of India)
Drug Alias NameCpG 1018 adjuvanted Tdap vaccine (Dynavax Technologies/Serum Institute of India)Tdap-1018 CpG Adjuvanted (Dynavax Technologies/Serum Institute of India)Tdap-1018
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsWhooping Cough
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDynavax Technologies CorpSerum Institute Of India Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDynavax Technologies Corp
Inactive CompaniesN/A
Active IndicationsWhooping Cough
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A